Werner Syndrome
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Gene expression changes that were common to all three cell types included up-regulation of GCK (glucokinase), CS (citrate synthase), HOX1 (heme oxygenase 1), CKMT2 (mitochondrial creatine kinase 2), MYC (v-myc myelocytomatosis viral oncogene homolog), and WRN (Werner syndrome helicase), and down-regulation of FBP1 (fructose-1, 6-bisphosphatase 1) and COL4A1 (collagen, type IV, alpha 1).
|
15561107 |
2005 |
Weight decreased
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Triglycerides measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci.
|
23063622 |
2012 |
Triglycerides measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetics of blood lipids among ~300,000 multi-ethnic participants of the Million Veteran Program.
|
30275531 |
2018 |
Triglycerides measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Bivariate Genome-Wide Association Scan Identifies 6 Novel Loci Associated With Lipid Levels and Coronary Artery Disease.
|
30525989 |
2018 |
Tremor of hands
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Transient neonatal diabetes mellitus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Transient hypothyroxinaemia of prematurity
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
This study aims to address effects of TCH on mRNA expressions of glucose transporters (GLUTs) and glucokinase (GcK) in islets and insulin target tissues of aged offspring rats.
|
29073628 |
2017 |
Tonic - clonic seizures
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Systolic Pressure
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Streptozotocin Diabetes
|
0.300 |
Biomarker
|
disease |
CTD_human |
Chronic hyperglycemia, independent of plasma lipid levels, is sufficient for the loss of beta-cell differentiation and secretory function in the db/db mouse model of diabetes.
|
16123366 |
2005 |
Steatohepatitis
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
This suggests that increased GCK activity may induce fatty liver and its metabolic and hepatic consequences in humans.
|
21490074 |
2011 |
Steatohepatitis
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
The up-regulation of expression of hepatic genes related to liver steatosis (CPT1A, FASN, LEPR, RXRA, IGFBP1, PPARGC1A and SLC2A4) was detected in our rhesus model, as was the down-regulation of such genes (CYP7A1, HMGCR, GCK and PNPLA3) and the up-regulation of expression of hepatic genes related to liver cancer (E2F1, OPCML, FZD7, IGFBP1 and LEF1).
|
26442469 |
2015 |
Steatohepatitis
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Genetic ablation of SIN3A abolishes nutrient regulation of glucokinase without affecting other FOXO1 target genes and lowers glycemia without concurrent steatosis.
|
29056338 |
2017 |
Small for gestational age fetus
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Small for gestational age (disorder)
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Situs Inversus
|
0.010 |
Biomarker
|
disease |
BEFREE |
Novel deletion mutation in the glucokinase gene from a korean man with GCK-MODY phenotype and situs inversus.
|
30086370 |
2018 |
Simple renal cyst
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Short nose
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Severe intellectual disability
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Severe hypoglycaemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Patients treated with insulin experienced a 23% incidence of severe hypoglycemia and lower birth weights were observed in the insulin-treated, GCK-affected neonates.
|
30535721 |
2019 |
Serum albumin measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Large-scale genome-wide association studies in East Asians identify new genetic loci influencing metabolic traits.
|
21909109 |
2011 |
Serum albumin measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
A genome-wide assessment of variability in human serum metabolism.
|
23281178 |
2013 |
Seizures
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Secondary Neoplasm
|
0.010 |
Biomarker
|
group |
BEFREE |
Here, we report that transgenic GLK promotes tumor metastasis and cell migration through the scaffold protein IQ motif-containing GTPase-activating protein 1(IQGAP1).
|
31431460 |
2019 |